Guidelines & Advice

Treatment

Treatment is determined by the type and stage of cancer, as well as by what treatments and services a patient chooses. The guidelines and other documents available here focus on topics related to the treatment of cancer in Ontario.

Multidisciplinary Cancer Conferences

Displaying Guidelines

175 Items

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Document Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Updated

Mar 2025

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Document Status: Current
ID: GL END 9-10
Version: 2

Aug 2022

Best Practice Guidance for Patient-Specific Quality Assurance for IMRT and VMAT Plan Delivery Verification

Document Status: Current

Oct 2019

Best-Practice Guidance for Radiation Treatment Plan Physics Review

Document Status: Current

Apr 2020

Best Practice Recommendations for Regimen Development and Maintenance

Document Status: Current
ID: GL-C50-25

Feb 2016

Breast Irradiation in Women with Early Stage Invasive Breast Cancer Following Breast Conserving Surgery

Document Status: Education and Information
ID: 1-2
Version: 2

Sep 2011

Cancer Care Ontario Beyond-Use Date Recommendations Report

Document Status: Current
ID: N/A
Version: 1

Mar 2018

Cancer Care Ontario’s Focus on Take-Home Cancer Drugs and Community Practice

Document Status: Current
ID: GL-C50-17

Jan 2015

Cannabis and cannabinoids: Cancer risk and use to manage cancer symptoms

Document Status: Current
ID: N/A
Version: 2

Jan 2023

Clarifying the Roles of Clinical Nurse Specialists and Nurse Practitioners in Delivery of Cancer Care in Ontario

Document Status: Current
ID: GL-C50-06

Jan 2018

Clinical Utility of Positron Emission Tomography in the Diagnosis, Staging and Management of Sarcoidosis

Document Status: Current
ID: PET 11

Aug 2011

Clinical Verification of Cancer Drug Prescriptions Checklist: Cancer Centres and Specialty Pharmacies

Document Status: Current
ID: GL-C50-18

Jan 2015